The PP2A inhibitor SET regulates granzyme B expression in human natural killer cells

Blood

Volumn 117, Issue 8, 2011, Pages 2378-2384

  Trotta, Rossana ^a   Ciarlariello, David ^a   Col, Jessica Dal ^a   Mao, Hsiaoyin ^a   Chen, Li ^a   Briercheck, Edward ^a   Yu, Jianhua ^a   Zhang, Jianying ^a   Perrotti, Danilo ^a,b   Caligiuri, Michael A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,9 DIDEOXYFORSKOLIN; CELL SURFACE RECEPTOR; CYTOKINE RECEPTOR; GRANZYME B; INTERLEUKIN 15; MESSENGER RNA; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE 2A; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PROTEIN SET; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; GENE EXPRESSION; HUMAN; HUMAN CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 79952133244     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-285130     Document Type: Article

References (33)

1. Caligiuri MA. Human natural killer cells. Blood. 2008;112(3):461-469.
2. Perussia B. Fc receptors on natural killer cells. Curr Top Microbiol Immunol. 1998;230:63-88. (Pubitemid 28183718)
3. Lieberman J. The ABCs of granule-mediated cytotoxicity: new weapons in the arsenal. Nat Rev Immunol. 2003;3(5):361-370. (Pubitemid 37323196)
4. Zamai L, Ahmad M, Bennett IM, Azzoni L, Alnemri ES, Perussia B. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J Exp Med. 1998;188(12):2375- 2380. (Pubitemid 29028510)
5. Fehniger TA, Cai SF, Cao X, et al. Acquisition of murine NK-cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 2007;26(6):798-811. (Pubitemid 46907665)
6. Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci U S A. 1995;92(12):5679-5683.
7. Zhang B, Zhang J, Tian Z. Comparison in the effects of IL-2, IL-12, IL-15 and IFNalpha on gene regulation of granzymes of human NK cell line NK-92. Int Immunopharmacol. 2008;8(7):989-996.
8. Huang C, Bi E, Hu Y, et al. A novel NF-kappaB binding site controls human granzyme B gene transcription. J Immunol. 2006;176(7):4173-4181. (Pubitemid 44264397)
9. Salcedo TW, Azzoni L, Wolf SF, Perussia B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J Immunol. 1993;151(5):2511-2520. (Pubitemid 23264503)
10. Janssens V, Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J. 2001;353(3):417-439. (Pubitemid 32158309)
11. Li M, Makkinje A, Damuni Z. The myeloid leukemia-associated protein SET is a potent inhibitor of protein phosphatase 2A. J Biol Chem. 1996;271(19):11059-11062. (Pubitemid 26155931)
12. Neviani P, Santhanam R, Trotta R, et al. The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein. Cancer Cell. 2005;8(5):355-368. (Pubitemid 41579831)
13. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J. Tumor suppressor NM23-H1 is a granzyme Aactivated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell. 2003;112(5):659-672. (Pubitemid 36331778)
14. Seo SB, McNamara P, Heo S, Turner A, Lane WS, Chakravarti D. Regulation of histone acetylation and transcription by INHAT, a human cellular complex containing the set oncoprotein. Cell. 2001;104(1): 119-130. (Pubitemid 32144977)
15. Millward TA, Zolnierowicz S, Hemmings BA. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci. 1999;24(5): 186-191. (Pubitemid 29348452)
16. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal. 2001;13(1): 7-16. (Pubitemid 32222967)
17. Kawada M, Kawatsu M, Masuda T, et al. Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells. Int Immunopharmacol. 2003;3(2):179-188. (Pubitemid 36183377)
18. McVicar DW, Mason AT, Bere EW, Ortaldo JR. Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid. Eur J Immunol. 1994;24(1): 165-170. (Pubitemid 24014693)
19. Trotta R, Ciarlariello D, Dal Col J, et al. The PP2A inhibitor SET regulates natural killer cell IFN-gamma production. J Exp Med. 2007;204(10): 2397-2405. (Pubitemid 47529325)
20. Picchio MC, Martin ES, Cesari R, et al. Alterations of the tumor suppressor gene Parkin in non-small cell lung cancer. Clin Cancer Res. 2004;10(8):2720-2724. (Pubitemid 38509147)
21. Becknell B, Trotta R, Yu J, et al. Efficient infection of human natural killer cells with an EBV/retroviral hybrid vector. J Immunol Methods. 2005;296(1-2): 115-123. (Pubitemid 40174745)
22. Trotta R, Col JD, Yu J, et al. TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells. J Immunol. 2008; 181(6):3784-3792.
23. Trotta R, Vignudelli T, Candini O, et al. BCR/ABL activates mdm2 mRNA translation via the La antigen. Cancer Cell. 2003;3(2):145-160. (Pubitemid 37443387)
24. Trotta R, Kanakaraj P, Perussia B. Fc gamma R-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-alpha and early activation genes. J Exp Med. 1996; 184(3):1027-1035.
25. Trotta R, Puorro KA, Paroli M, et al. Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK-cell cytotoxicity on extracellular signal-regulated kinases. J Immunol. 1998;161(12):6648-6656. (Pubitemid 28562206)
26. Trinchieri G. Biology of natural killer cells. Adv Immunol. 1989;47:187-376. (Pubitemid 20010960)
27. Vesosky B, Rottinghaus EK, Davis C, Turner J. CD8 T cells in old mice contribute to the innate immune response to Mycobacterium tuberculosis via interleukin-12p70-dependent and antigenin-dependent production of gamma interferon. Infect Immun. 2009;77(8):3355-3363.
28. de Rham C, Ferrari-Lacraz S, Jendly S, Schneiter G, Dayer JM, Villard J. The proinflammatory cytokines IL-2, IL-15 and IL-21 modulate the repertoire of mature human natural killer cell receptors. Arthritis Res Ther. 2007;9(6):R125.
29. Decot V, Voillard L, Latger-Cannard V, et al. Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impact on NKG2D, KIR2DL1, and KIR2DL2 expression. Exp Hematol. 2010;38(5):351-362.
30. Djeu JY, Jiang K, Wei S. A view to a kill: signals triggering cytotoxicity. Clin Cancer Res. 2002; 8(3):636-640. (Pubitemid 34745987)
31. Milella M, Gismondi A, Roncaioli P, et al. CD16 cross-linking induces both secretory and extracellular signal-regulated kinase (ERK)-dependent cytosolic phospholipase A2 (PLA2) activity in human natural killer cells: involvement of ERK, but not PLA2, in CD16-triggered granule exocytosis. J Immunol. 1997;158(7):3148-3154. (Pubitemid 127484028)
32. Wei S, Gamero AM, Liu JH, et al. Control of lytic function by mitogen-activated protein kinase/extracellular regulatory kinase 2 (ERK2) in a human natural killer cell line: identification of perforin and granzyme B mobilization by functional ERK2. J Exp Med. 1998;187(11):1753-1765.
33. Wargnier A, Legros-Maida S, Bosselut R, et al. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: implication of Ikaros and CBF binding sites in promoter activation. Proc Natl Acad Sci U S A. 1995;92(15):6930-6934.